Cuba could begin in March the emergency use of some of its vaccine candidates against Covid-19 to immunize high-risk people, it was reported on Monday.
Eduardo Martinez, president of the Biotechnology and Pharmaceutical Industries Group, BioCubaFarma, told Russia Today television that Cuba shows very positive results with its vaccines Soberana 01, Soberana 02, Mambisa (CIGB-669) and Abdala (CIGB-66).
'The clinical Phase 3 trials of the vaccine that goes ahead could begin in March. As of the results, and knowing those of other vaccine candidates internationally, we could aspire to an emergency use to start doing mass vaccinations for high-risk people,' Martinez said.
He also said that Cuba is working and can successfully achieve 'more than one vaccine' for different populations.
'One vaccine for children and another one perhaps for a group of people aged 19 and 60 years. That has not yet been defined, but it may be that way,' Martinez said.
The scientist stressed the need that Cuba can obtain its own vaccine, as a matter of sovereignty and due to the shortage and the costs involved in importing another vaccine.
In this way, Cuba would also be one of the first nations to implement a massive vaccination campaign, he stated.
CubaPLUS Latinos
CubaPLUS Guyana
CubaPLUS Travel